Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Current Medicinal Chemistry|June 23, 2007
Molecular probes for P2X7 receptor studiesHendra Gunosewoyo, Mark J Coster, Michael Kassiou
Bioorganic & Medicinal Chemistry|June 23, 2009
Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screeningHendra Gunosewoyo, Mark J Coster, Maxwell R Bennett, et al.
Expert Opinion on Therapeutic Patents|March 9, 2010
P2X purinergic receptor ligands: recently patented compoundsHendra Gunosewoyo, Michael Kassiou
Bioorganic & Medicinal Chemistry Letters|June 6, 2008
Cubyl amides: novel P2X7 receptor antagonistsHendra Gunosewoyo, Jun Liu Guo, Maxwell R Bennett, et al.
Future Medicinal Chemistry|February 9, 2017
Kinase targets in CNS drug discoveryHendra Gunosewoyo, Lifang Yu, Lenka Munoz, et al.
International Journal of Molecular Sciences|March 29, 2023
Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug TargetsShahinda S R Alsayed, Hendra Gunosewoyo
International Journal of Molecular Sciences|November 27, 2024
Combating Tuberculosis via Restoring the Host Immune Capacity by Targeting <i>M. tb</i> Kinases and PhosphatasesShahinda S R Alsayed, Hendra Gunosewoyo
Bioorganic & Medicinal Chemistry Letters|December 4, 2009
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modelingSamuel D Banister, Iman A Moussa, Meredith J T Jordan, et al.
European Journal of Pharmacology|November 23, 2006
Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effectsXiang Liu, Samuel D Banister, MacDonald J Christie, et al.
Pageof 30